Association Between a Novel MTV-Based Effective Absorbed Dose Index and ALBI Score Changes in Metastatic Colorectal Cancer Patients Treated with Yttrium-90 Glass Microspheres
This study demonstrates that a novel MTV-based Effective Absorbed Dose Index, derived from the ratio of tumour to non-tumoural liver absorbed doses, is significantly associated with stable liver function (ALBI score) in metastatic colorectal cancer patients treated with Yttrium-90 glass microspheres, suggesting its potential utility for optimizing individualized treatment planning and risk stratification.